AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results
阿斯利康阿斯利康(US:AZN) WSJ·2026-03-31 20:23

药物研发进展 - 公司表示其药物有潜力改变低磷酸酯酶症的治疗格局 [1] - 公司计划尽快向监管机构提交相关数据 [1]

AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results - Reportify